| Primary information |
|---|
| sequence ID | Seq_3544 |
| Peptide sequence | HTDLSGKVFVFPRE |
| CancerPDF_ID | CancerPDF_ID10235, CancerPDF_ID11605, |
| PMID | 21805675,26992070 |
| Protein Name | Serum amyloid P-component,Serum amyloid P-component |
| UniprotKB Entry Name | SAMP_HUMAN,SAMP_HUMAN |
| Fluid | Urine,Serum |
| M/Z | 1631.8474,NA |
| Charge | NA,NA |
| Mass (in Da) | NA,1631.856968 |
| fdr | NA,NA |
| Profiling Technique | MALDI-TOF,LC-MS |
| Peptide Identification technique | MALDI-TOF-MS,LC-MS/MS |
| Quantification Technique | NA,NA |
| Labelled/Label Free | Label Free,Label Free |
| FDR | 1,FDR 1 % |
| CancerPDF_ID | CancerPDF_ID10235, CancerPDF_ID11605, |
| p-Value | NA,NA |
| Software | NA,SEQUEST and Maxquant |
| Length | 14,14 |
| Cancer Type | Muscle-invasive bladder cancer,Melanoma |
| Database | SwissProt Database,SwissProt Database |
| Modification | NA,NA |
| Number of Patients | 751 bladder cancer and 127 control,8 cancer samples and 4 healthy samples |
| Regulation | Differentially expressed between cancer vs normal samples,"Present in 3 cancer samples out of 8 cancer samples. ,Present in 0 healthy samples out of 4 healthy samples." |
| Validation | Mann-Whitney tests and areas under receiver-operator characteristic,na |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | NA |
| IEDB | |